Rachel E. Sachs, JD, MPH; Paul B. Ginsburg, PhD; Dana P. Goldman, PhD
JAMA. 2017;318(24):2421-2422. doi:10.1001/jama.2017.17535
This Viewpoint discusses ways in which government agencies could encourage discovery of new indications for older, off-patent drugs.
Jennifer B. Nuzzo, DrPH, SM; Anita J. Cicero, JD; Thomas V. Inglesby, MD
JAMA. 2017;318(24):2423-2424. doi:10.1001/jama.2017.17188
This Viewpoint discusses the importance of the United States’ commitment to support the Global Health Security Agenda to help protect the nation and the world from epidemic disease.
Arthur J. Barsky, MD
JAMA. 2017;318(24):2425-2426. doi:10.1001/jama.2017.16216
This Viewpoint discusses how physicians’ choice of words can amplify patients’ symptoms and distress and suggests approaches to communication in common situations that could reduce iatrogenic nocebo effects.
David J. Smith, MD, MS; Raquel C. Bono, MD, MBA; Bryce J. Slinger, MPH
free access
JAMA. 2017;318(24):2427-2428. doi:10.1001/jama.2017.16718
This Viewpoint describes the five lines of reform the US Department of Defense is implementing for its TRICARE health plan, the main provider of health care services to enlisted service members in all military branches, their families, and retirees.